AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
3min chapter
How a big biotech’s start-up gamble went wrong
Behind the Money
The Importance of Investors Hungering for Returns in Startups
Illumina, the company behind grail's cancer screening technology, is facing a proxy battle. Investors worried that Illumina's ambitious strategy of buying grail had just gone wrong. Behind the Money looks at whether investors hungry for returns will get in the way of a startup's ambitious goals.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode